Abstract | Pure vascular parkinsonism without evidence of nigral Lewy body pathology may occur as a distinct clinicopathological entity, but a much more frequent occurrence is the comorbid presence of age-associated white matter lesions (WMLs) in idiopathic Parkinson disease (PD). WMLs are associated with motor and cognitive symptoms in otherwise normal elderly individuals. Comorbid WMLs are, therefore, expected to contribute to clinical symptoms in PD. Studies of WMLs in PD differ with regard to methods of assessment of WML burden and the patient populations selected for analysis, but converging evidence suggests that postural stability and gait motor functions are predominantly affected. WMLs are described to contribute to dementia in Alzheimer disease, and emerging but inconclusive evidence indicates similar effects in PD. In this article, we review the literature addressing the occurrence and impact of WMLs in PD, and suggest that WMLs may exacerbate or contribute to some motor and cognitive deficits associated with PD. We review existing and emerging methods for studying white matter pathology in vivo, and propose future research directions.
Introduction
White matter lesions (WMLs), also known as leuko araiosis, are commonly observed on imaging studies in older adults, and may present as signal hyperintensities on T2weighted MRI studies. 1 Ageassociated WMLs are related to balance impairment, mobility and cognitive deficits in otherwise healthy elderly individuals. [2] [3] [4] [5] Given that some of these dysfunctions overlap with features of Parkinson disease (PD), comorbid WMLs are predicted to contribute to clinical symptoms in this condition.
This Review will focus on the comorbid presence of WMLs in patients with idiopathic PD, and its relation ship with motor and cognitive symptoms. We briefly review the contribution of WMLs to declining motor and cognitive function in aging, the contribution of vascular pathology to parkinsonism, and established and emerg ing methods for evaluating WMLs. We then provide a detailed review of studies of WMLs in patients with PD, and a discussion of the probable clinical correlates of WMLs in PD and interactions with neurodegenerative pathology in this condition. We conclude by discussing possible future research on WMLs and PD.
Presence of white matter lesions
Nondisabled elderly individuals The Leukoaraiosis and Disability (LADIS) study found that the presence of WMLs in nondisabled elderly people was associated with a history of falls, and corre lated with mobility impairments, such as decreased walking speed, decreased balance, and reduced physi cal acti vity levels. 4 WMLs have also been linked with deficits in attention, executive functions and processing speed in the elderly. 6, 7 In 2010, Murray et al. reported WML burden, cogni tive data and motor data from wellcharacterized non demented elderly individuals without PD. 1 In this cohort, WML burden in several regions of the brain was inversely correlated with executive function but did not correlate with memory, language or visuo spatial dysfunction. In terms of motor function, increasing WML burden cor related with reduced gait velocity and worsen ing Unified PD Rating Scale (UPDRS) scores for gait, posture and postural instability. In a study involving a large cohort of healthy elderly individuals (n = 429; age range 50-85 years), de Laat et al. described WMLs associ ated with gait abnormalities-specifically, slower gait speed, reduced stride length, and increased stride width. 8 
Vascular pathology and parkinsonism
WMLs are thought to occur in the context of cardio vascular disease. 9 One neuropathological study found evidence of an association between WMLs and loss of vascular integrity, indicating a vascular origin for these lesions. 10 Vascular damage may, in turn, impair bloodbrain barrier integrity, thus providing one mechanism though which WMLs could evolve. MRI-pathological correlation studies of periventricular WMLs revealed correlated vascular changes including arteriolar tortuo sity, reduced vessel density, and occlusive venous colla genosis associated with venous insufficiency and vasogenic edema. [11] [12] [13] In addition, activated microglia, oligo dendroglial apoptosis, clasmatodendritic astro cytosis, and up regulation of hypoxiaassociated markers were found.
Periventricular WMLs are suggested also to result from a reduction in myelin density due to Wallerian degenera tion secondary to primary neocortical neuron loss. degeneration was a major contributor. 12 Other pos sible mechanisms involved in WML formation include hypotension, 15 lowgrade inflammation, 16 and metabolic factors, such as vitamin B 12 deficiency. 17 Parkinsonism due to cerebrovascular disease in the absence of Lewy body pathology (vascular parkinsonism) is a distinct clinicopathological entity, and may account for 4-12% of all cases of parkinsonism. 18, 19 Commonly noted lesions on brain imaging in vascular parkinsonism are lacunes, WMLs and, in rare cases, largevessel infarcts. 18, 20 In a consecutive autopsy series of 700 cases with a clini cal diagnosis of parkinsonism, 27 brains (3.9%) showed subcortical vascular lesions in the basal ganglia, white matter or brainstem, with no signifi cant nigral lesions. 21 In the UK Parkinson's Disease Society Brain Bank clinico pathological series, three of 24 cases misdiagnosed by spe cialist neurologists as idiopathic PD during life exhibited postmortem evidence of a lacunar state without charac teristic Lewy body pathology. 22 Although a pure vascular etiology exists for a small subset of patients with parkin sonism, comorbid postmortem vascular lesions are much more common, and have been reported in 19-50% of patients with Lewy bodyconfirmed PD. 21, 23, 24 In vivo imaging studies show WMLs to be present in 30-55% of patients with PD. [25] [26] [27] Some studies also suggest that WMLs are more common in patients with PD than in normal elderly individuals. [28] [29] [30] Other studies, however, failed to find an increased incidence of WMLs in PD. 25, 31, 32 Marked agerelated changes have been observed in the central dopamine system. 33 An average person may lose ≈33% of striatal dopaminergic innervation between the ages of 25 and 75 years, 34 although this figure is not as severe as in PD, where losses often exceed 50-80%. 35 According to estimates, ≈50% of dopaminergic cells must be destroyed, with an 80% reduction in posterior puta minal dopaminergic innervation, before specific clini cal signs and symptoms of PD become manifest. [35] [36] [37] The combined presence of subclinical ageassociated nigro striatal dopaminergic loss and WMLs may, however, cause motor impairments in the elderly. For example, Louis and colleagues described mild parkinsonian fea tures associated significantly with WML burden in 16.7% of communitydwelling elderly individuals. 38 WMLs might, conceivably, lower the threshold for developing parkinsonian symptoms in elderly people with age associated and pathological nigrostriatal dopaminergic losses ( Figure 1 ).
Imaging white matter lesions
WMLs can be recognized on CT scans, but MRI scansin particular, T2weighted or fluidattenuated inversion recovery (FLAIR) sequences-are most commonly used for their identification. WMLs appear as punctate or moreconfluent hyperintense areas on these sequences, and are often referred to as white matter hyper intensities. Visual rating scales, each with emphases on different aspects of WMLs, have been developed to estimate WML burden. [39] [40] [41] [42] The most comprehensive scale was developed by Scheltens and colleagues. 42 In this scale, WML burden is assessed on the basis of size and quantity of lesions in a given neuroanatomical location, includ ing periventricular and nonperiventricular WMLs. Periventricular hyperintensities are further separated into frontal, occipital and lateral regions.
Other rating scales for WMLs are the BrantZawadzki et al. scale 39 and the Cardiovascular Health Study Scale, 41 both of which place relatively high emphasis on periventricular WMLs. Unlike the Scheltens scale, these two rating scales do not specifically assess the dif ferent periventricular regions. Periventricular WML burden is often proportional to the overall burden. 43, 44 Furthermore, the burden of WMLs around the frontal ventricular horns may be of particular importance, given the potential to disrupt several important subcortical afferent and cortical efferent projections. 45 Semiquantitative visual assessments of WML burden are limited by grader dependence: intergrader vari ability may affect the reliability of these measures and limit comparison across studies. With increasing magnetic field strengths, white matter abnormalities become more complex and dif ficult to define by visual inspection. Punctate and conflu ent white matter areas are observed that appear to be below a threshold to classify easily as hyperintensities-these are sometimes referred to as 'dirty' white matter.
Automated routines have also been developed to define WML burden. These methods are typically based on segmentation of white matter MRI series, threshold ing of hyperintense white matter voxels, or 'fuzzy' neighbor ing clusterbased voxel analysis. A different approach involves use of a reference region or tissue, such as intensity of normal gray matter 46 or the cere bellar white matter, which usually has few ageassociated WMLs. 47 These methods have the advantage of improved quantitative assessment of WML burden compared with visual grading, and might be particularly advantageous for assessing changes over time.
Diffusion tensor imaging (DTI) is an MRI technique that examines the local microenvironmental charac teristics of water diffusion and is used to evaluate the integrity of white matter fiber tracts. DTI measures of the magnitude and direction of water diffusion are termed mean diffusivity and fractional anisotropy, the former being a measure of water diffusivity and the latter being a measure of tract directionality and integrity. 48 DTI mea sures were recently shown to add significantly to assess ment of WMLs in studies of healthy elders. 8 A DTI study published in 2009 showed evidence of microstructural WMLs in early PD, most prominently in the genu of the corpus callosum and in the superior longitudinal fasci culus, suggesting connectivity changes in the frontal and parietal white matter. 49 Another study found decreased fractional anisotropy in the frontal lobes in PD patients without cognitive impairment and with no evidence of brain volume loss. 50 These data suggest that widespread microstructural damage to frontal and parietal white matter occurs in early stages of PD, and may occur before hyperintensities are visually apparent on T2weighted MRI. DTI could be par ticularly valuable for studying WMLs in earlier stages of the disease, and DTI of the corpus callosum offers a unique window to study regional disruption in the interhemi spheric connection during neuro degeneration. 51 Figure 2 shows examples of FLAIR and DTI scans in PD patients without and with significant FLAIR hyper intensities. Despite the lack of specific FLAIR hyper intensities in the former patient, the fractional anisotropy of the anterior corona radiata suggests mild micro structural changes in the frontal lobe white matter.
White matter lesions in PD
Motor correlates Although some studies failed to report an associa tion between WMLs and motor impairments in PD, 52 evidence is accumulating that WMLs independently contribute to postural and gait disturbances in this condition. Sohn and Kim, for example, found that comorbid WMLs were associated with moresevere gait problems but not with symptoms of tremor, pure brady kinesia or rigidity. 25 Subcortical but not peri ventricular WMLs were related to moresevere gait symptoms and rigidity. Piccini et al. found that patients with PD and comorbid WMLs had moresevere symptoms of brady kinesia, gait disturbance and postural instability than PD patients without WMLs. 29 The same authors found that the presence of periventricular but not sub cortical WMLs was associated with moresevere clinical symptoms and morerapid disease progression. In a study of 141 patients with PD, Lee et al. found that WML burden corre lated significantly with postural and gait impairments, speech, facial expression, bradykinesia, and-to a lesser degree-rigidity, but not with tremor. 27 Comparison of agematched groups with the postural instability gait difficulty (PIGD) motor and tremor dominant pheno types of PD demonstrated significantly increased WML burden in the PIGD group. 27 Acharya et al. found that agerelated brain MRI changes super imposed on PD corre lated positively with the number of steps and walking time to complete a gait task but did not correlate with total parkinsonian motor scores. No studies have yet directly compared the presence or severity of WMLs with the degree of nigrostriatal dopaminergic denervation and motor symptoms in PD. We have preliminary data showing that increased WML burden is associated with worsening motor performance in PD independent of the degree of nigrostriatal dopa minergic denervation, as determined by PET imaging. We also found that comorbid WMLs are a greater deter minant of balance impairment than is nigrostriatal dopa minergic denervation in PD. 53 
Cognitive correlates
Cognitive decline is a frequent finding in PD patients, with point prevalence estimated at up to 40% for demen tia and at >60% for executive dysfunction 54, 55 The cumu lative prevalence of dementia is very high, and at least 75% of patients with PD who survive for >10 years will develop dementia. 56 WMLs are described to contribute to dementia in Alzheimer disease, 57, 58 and evidence-as yet inconclusive-is emerging of similar effects in PD with dementia. 59, 60 Choi and colleagues, for example, found preliminary evidence that comorbid WMLs increase the risk of dementia more than twofold in patients with PD. 24 Beyer and colleagues also explored whether WMLs were associated with dementia in PD. 61 35 patients with PD-16 with dementia and 19 without dementiaand 20 control individuals were included in this study. Cerebrovascular risk factors, education, sex ratios and age distributions were similar across groups. Compared with the PD group, the PD with dementia (PDD) group had significantly higher levels of periventricular and deep WMLs. Deep white matter WML burden was the only variable associated significantly with Mini Mental State Examination scores, and explained 38% of the cog nitive score variance in a multivariate linear regression analysis. 61 These findings suggest that WMLs in the deep white matter may contribute to dementia in PD.
Lee and colleagues used the Scheltens et al. rating scale to assess WMLs in a consecutive series of 71 patients with PD, including some with PDD. 62 These authors found that patients with PDD had significantly more supra tentorial WMLs-in particular, periventricular WMLsthan the PD group. A linear regression model indicated that WMLs were independently associated with cogni tive impairments in PD, regardless of age, sex, duration or severity of PD symptoms, and vascular risk factors. 62 Moresevere WMLs correlated with more profound cognitive deficits, including impairments in attention, visuospatial, memory and executive functions.
Other studies, one of which involved newly diagnosed PD patients without dementia, have failed to find signifi cant diseasespecific cognitive correlates of WMLs. 26, 63 Although these studies reported a significant inverse correlation between WML burden and scores on tests of attention and executive functions, this correlation vanished on ageadjusted multiple regression analysis. Similar results were reported in a study by Dalaker and colleagues. 32 The ageuncorrected correlation coefficients between WMLs and cognition, however, were stronger in the PD group than in the agematched control group.
These findings suggest a significant interaction between the effects of age and WMLs in PD. Another possi bility is that the cognitive effects of comorbid WMLs may be more easily detectable in advanced stages of neuro degeneration, such as in PDD. 64 A recent study compared the neuropsychological pro files of parkinsonian patients with and without vascular lesions on MRI, all of whom were confirmed to have nigrostriatal dopaminergic denervation on dopamine transporter imaging. 65 PD patients with comorbid WMLs performed less well on tests of executive function and attention than did control PD patients.
Further studies examining the relationship between WMLs and specific cognitive domains are needed. In addition, no published studies have directly compared the effects of nigrostriatal dopaminergic denerva tion and WMLs in PD. We have, however, obtained preliminary data indicating that increased WML burden is associated with worsening cognitive perfor mance in PD independent of the degree of nigrostriatal dopaminergic denervation. 66 
Clinical features
Accumulating evidence from studies of the correlates of WMLs in normal elderly individuals and patients with PD suggest that WMLs might cause or exacerbate some features of PD. WMLs could cause or exacerbate motor or cognitive features through several mechanisms. First, any gray matter vascular lesion-the patho genesis of which is probably driven by the same vascular risk factors that lead to WMLs-involving the substantia nigra or a sufficient volume of striatum can produce 'parkinsonism'. 19, 67 Second, WMLs may disrupt the corticostriatal-thalamocortical loops. 68 Periventricular WMLs may reflect damage of both periventricular ascending thalamocortical and descending cortico spinal fibers, especially those from the medial frontal cortex that project to the lower extremities. These fibers pass close to the lateral ventricles before enter ing the internal capsule, and WMLs could interfere with longloop reflexes that are critical for gait and balance. Third, WMLs might disrupt the interhemispheric con nections of the corpus callosum, which are critical for complex integrated motor programs, such as bipedal walking. Last, WMLs may disrupt important sub cortical afferents. For example, WMLs underlying the frontal lobes and residing within periventricular regions may destroy projection fibers originating from sub cortical mono aminergic and cholinergic nuclei, including dopa minergic fibers originating from the ventral tegmental area that project to the mesofrontal and limbic cortex, 47 and cholinergic projections from the nucleus basalis of Meynert (Figure 3) . WMLs of the deep frontal lobe could result in cortical cholinergic deafferentation and related cognitive impairment in elderly individuals without PD. 45 More speculatively, WML burden might also be associ ated with depression, which is another prominent feature of PD. As discussed in a systematic review, 69 some studies suggest that WML burden is a risk factor for latelife depression. Frontal lobe WMLs have been implicated in depression in PD, and increased WML burden could be an additional risk factor in this setting.
WMLs of the longitudinal fasciculus may preferen tially affect executive cognitive functions. 69 WMLs at the level of the brainstem might interfere with sensorimotor afferent and efferent cortical projections (Table 1) . Taken together, these observations suggest that supratentorial and brainstem WMLs interfere with central processing of sensorimotor signals, leading to impaired postural responses and gait functions. 70 Such effects might be more prominent in a hypodopaminergic state such as PD.
Motor correlates of WMLs in idiopathic PD may to some degree overlap with typical vascular parkin sonian symptoms. When compared with idiopathic PD, typical motor symptoms in pure vascular parkinsonism tend to be more symmetrical, affecting the lower limbs more than the arms ('lowerbody parkinsonism'), and resting tremor is usually absent. 18, [71] [72] [73] The gait pattern in patients with subcortical arteriosclerotic encephalopathy (Binswanger disease) has been described as having ele ments of both parkinsonian gait and ataxia, with the dif ficulty in using the legs to walk being out of proportion to that of other movements of the lower limbs when lying or seated. 74 Postural instability, freezing, gait disturbance, and pyramidal signs have been found to be significantly more prevalent in patients with vascular parkinsonism than in idiopathic PD. 18 In view of the prominent nigrostriatal pathology in PD, and because postural instability is a cardinal feature of the condition, the historical assumption has been that postural instability is attributable mainly to striatal dopa minergic denervation. 75 Balancerelated deficits are, however, the features that are least responsive to levodopa treat ment, 76 and nondopaminergic mechanisms, including degenera tion of the pedunculopontine-thalamic choliner gic system, contribute substantially to impaired balance in PD. 75, 77 Postural control is not simply a summation of static reflexes but involves complex coor dination and integration of visual, somatosensory and vestibular systems. The relative emphases placed on each of these sensory system inputs depend on the goals of the movement task and the environmental context. 78 Comorbid WMLs, therefore, are predicted to markedly interfere with postural control systems owing to the widespread and bilateral distribution of these neural systems.
Progression, treatment response and prognosis One study has reported moresevere clinical features in typical lateonset PD patients with a history of minor stroke, ischemic heart disease, or diabetes mellitus than in PD patients without such histories. 79 The presence of vascular disease might affect PD by aggravating symp toms in the same manner as in patients with vascular parkinsonism. Establishing the existence of synergis tic detrimental effects of PD and comorbid WMLs on disease progression and mobility impairment may lead to new therapeutic interventions, such as moreaggressive treatment of possible risk factors for WMLs, including the socalled 'metabolic syndrome' . 80 Therapies targeted at secondary prevention of WML progression might reduce axial motor and cognitive impairments in PD.
One study has examined the progression of WMLs in PD. Burton et al. looked at 1 year WML progression in older individuals clinically diagnosed with PDD or Alzheimer dementia. 60 The severity of WMLs at base line was the best predictor of 1 year progression in WML burden. This result implies that early and aggres sive management of vascular risk factors would be nec essary to have an impact on the severity of clinical features in PD. 79 A suggestion has been made that treating PD patients with dopaminergic medications might increase the risk of endothelial dysfunction and atherosclerosis by raising homocysteine levels. 81 At this point, this concern is entirely theoretical, as intervention studies do not support a major role for hyperhomocysteinemia in cerebro vascular disease or cognitive decline.
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Future directions
Improved quantification methods Studies on the relationship between comorbid WMLs and clinical features of PD have yielded variable results, probably at least partly owing to differences in the methods used to assess these lesions. Use of dif ferent rating scales and WML quantification algorithms, for example, impedes proper comparison of studies. Another common problem is the nonlinearity of scale units, which limits statistical analysis by linear regres sion. Moresensitive imaging techniques, such as DTI, are expected to give a better spread of data in people who have lower burdens of typical hyperintensities on T2weighted or FLAIR MRI. Some clinical features may be influenced by clinical threshold effects of WMLs before symptoms emerge, thereby limiting correlation analysis with WML ratings. 84 In addition, summed or global WML scores might be insensitive for symptoms related to topographically 'eloquent' locations of WMLs.
Future research should investigate the effects of strategically located WMLs, in particular those in peri ventricular frontal regions that could disrupt neuro modulator projection systems and result in mono aminergic and cholinergic cortical deafferentation ( Figure 3 and Table 1 ). Comprehensive analysis of brain smallvessel disease effects should not be limited to white matter, but should also include subcortical gray matter and provide regionally specific information. Most studies to date have been crosssectional in nature, and longitu dinal studies are needed to better and morespecifically evaluate the impact of WMLs and clinical symptoms in PD. Such investigations are of particular importance as the presence of the PIGD motor phenotype may be a risk factor for dementia in PD. 85 Combined gray and white matter imaging The presence of WMLs is associated with reduced corti cal perfusion, 86 and confluent WMLs are associated with up to 20% reductions in global cerebral blood flow. 87 Such relationships do not, however, establish that WMLs lead to diminished perfusion. Nevertheless, a combined MRI and glucose metabolic PET study suggested that WMLs preferentially affect glucose metabolism in the frontal lobes. 6 Studies are required that investigate how regional white matter integrity affects gray matter metabolism or perfusion, so as to unravel the complex link between white matter degeneration and cortical function, and to establish whether a synergistically detrimental effect exists. 88, 89 Gray matter studies should not be limited to the cortex, but should also involve subcortical gray matter, such as the basal ganglia and thalamus.
The amyloid cascade and white matter lesions Evidence is emerging for the existence of genetic risk factors for WMLs, which, in the case of microbleeds, may involve the amyloid cascade. 90 Amyloid pathology is often present when PD is complicated by dementia, 91 and the relationship between amyloid angiopathy and amyloidogenesis and occurrence of WMLs clearly needs to be elucidated. For example, cerebral apo lipo protein E leakage induced by smallvessel disease has been associated with amyloidβ deposition in peri vascular astrocytes. 92 Suggestions have been made that metabolic abnormalities that drive vascular risk factors also contribute to amyloidogenesis. 57 Even if this proves not to be the case, vascular injury to the brain might still have an additive effect on primary neurodegenerative processes.
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Conclusions
The association between comorbid WMLs and PD motor symptoms most consistently manifests in impair ment of axial motor symptoms. Correlations between WMLs and symptoms of rigidity and bradykinesia are less consistent. WMLs are likely to disrupt connectivity in widespread neural systems underlying bipedal stance and gait, which include corticostriatal-thalamocortical loops, interhemispheric fibers, striatothalamic-brainstem systems, and proper processing of multimodal sensory information. Evidence-albeit inconclusive-is accumu lating that cognitive effects of WMLs tend to preferentially affect executive functions, and may reflect frontal lobe WMLs. Preliminary evidence suggests that the detri mental cognitive effects of WMLs in PD could become more profound with increasing age, with preexisting cognitive impairment represent ing a possible threshold effect. New MRI methods are expected to provide moresensitive imaging tools to better charac terize and quantify the WML burden at a micro structural level in PD. WMLs could, plausibly, contribute to the clinical features of PD, raising the possibility that aggressive primary or secondary treatment of vascular or metabolic risk factors may affect the severity and progression of the disease. 
Review criteria
Articles for the Review were selected on the basis of a PubMed database search, using the following search terms: "Parkinson disease", "white matter", "leukoaraiosis", "motor", "cognitive" and "magnetic resonance imaging". Papers in the English language published between 1947 and 2010 were selected for review, and full-text versions were obtained. Additional references were identified from the publication lists of identified papers.
